Results
|
|
5901.
|
|
|
|
5902.
|
|
|
|
5903.
|
Phase I trial of neoadjuvant concurrent chemoradiotherapy with S-1 and weekly irinotecan in locally advanced rectal cancer. [electronic resource] by
- Choi, Hye Jin
- Kim, Nam-Kyu
- Keum, Ki Chang
- Cheon, Seong Ha
- Shin, Sang Jun
- Baik, Seung Hyuk
- Choen, Jae Hee
- Rha, Sun Young
- Roh, Jae Kyung
- Jeung, Hei-Cheul
- Chung, Hyun Cheol
- Ahn, Joong Bae
Producer: 20081105
In:
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology vol. 87
Availability: No items available.
|
|
|
5904.
|
The acridone derivative MBLI-87 sensitizes breast cancer resistance protein-expressing xenografts to irinotecan. [electronic resource] by
- Arnaud, O
- Boumendjel, A
- Gèze, A
- Honorat, M
- Matera, E L
- Guitton, J
- Stein, W D
- Bates, S E
- Falson, P
- Dumontet, C
- Di Pietro, A
- Payen, L
Producer: 20110714
In:
European journal of cancer (Oxford, England : 1990) vol. 47
Availability: No items available.
|
|
|
5905.
|
Correlation of capecitabine-induced skin toxicity with treatment efficacy in patients with metastatic colorectal cancer: results from the German AIO KRK-0104 trial. [electronic resource] by
- Stintzing, S
- Fischer von Weikersthal, L
- Vehling-Kaiser, U
- Stauch, M
- Hass, H G
- Dietzfelbinger, H
- Oruzio, D
- Klein, S
- Zellmann, K
- Decker, T
- Schulze, M
- Abenhardt, W
- Puchtler, G
- Kappauf, H
- Mittermüller, J
- Haberl, C
- Giessen, C
- Moosmann, N
- Heinemann, V
Producer: 20110909
In:
British journal of cancer vol. 105
Availability: No items available.
|
|
|
5906.
|
Combination of gastrin-releasing peptide antagonist with cytotoxic agents produces synergistic inhibition of growth of human experimental colon cancers. [electronic resource] by
- Rick, Ferenc G
- Buchholz, Stefan
- Schally, Andrew V
- Szalontay, Luca
- Krishan, Awtar
- Datz, Christian
- Stadlmayr, Andreas
- Aigner, Elmar
- Perez, Roberto
- Seitz, Stephan
- Block, Norman L
- Hohla, Florian
Producer: 20121116
In:
Cell cycle (Georgetown, Tex.) vol. 11
Availability: No items available.
|
|
|
5907.
|
|
|
|
5908.
|
Cytotoxic drugs up-regulate epidermal growth factor receptor (EGFR) expression in colon cancer cells and enhance their susceptibility to EGFR-targeted antibody-dependent cell-mediated-cytotoxicity (ADCC). [electronic resource] by
- Correale, Pierpaolo
- Marra, Monica
- Remondo, Cinzia
- Migali, Cristina
- Misso, Gabriella
- Arcuri, Felice Paolo
- Del Vecchio, Maria Teresa
- Carducci, Antonietta
- Loiacono, Lucia
- Tassone, Pierfrancesco
- Abbruzzese, Alberto
- Tagliaferri, Pierosandro
- Caraglia, Michele
Producer: 20101006
In:
European journal of cancer (Oxford, England : 1990) vol. 46
Availability: No items available.
|
|
|
5909.
|
Cetuximab plus irinotecan after irinotecan failure in elderly metastatic colorectal cancer patients: clinical outcome according to KRAS and BRAF mutational status. [electronic resource] by
- Fornaro, Lorenzo
- Baldi, Giacomo Giulio
- Masi, Gianluca
- Allegrini, Giacomo
- Loupakis, Fotios
- Vasile, Enrico
- Cupini, Samanta
- Stasi, Irene
- Salvatore, Lisa
- Cremolini, Chiara
- Vincenzi, Bruno
- Santini, Daniele
- Tonini, Giuseppe
- Graziano, Francesco
- Ruzzo, Annamaria
- Canestrari, Emanuele
- Magnani, Mauro
- Falcone, Alfredo
Producer: 20111017
In:
Critical reviews in oncology/hematology vol. 78
Availability: No items available.
|
|
|
5910.
|
|
|
|
5911.
|
|
|
|
5912.
|
|
|
|
5913.
|
IL-33 targeting attenuates intestinal mucositis and enhances effective tumor chemotherapy in mice. [electronic resource] by
- Guabiraba, R
- Besnard, A G
- Menezes, G B
- Secher, T
- Jabir, M S
- Amaral, S S
- Braun, H
- Lima-Junior, R C P
- Ribeiro, R A
- Cunha, F Q
- Teixeira, M M
- Beyaert, R
- Graham, G J
- Liew, F Y
Producer: 20151214
In:
Mucosal immunology vol. 7
Availability: No items available.
|
|
|
5914.
|
|
|
|
5915.
|
Treatment patterns and clinical outcomes in patients with metastatic colorectal cancer initially treated with FOLFOX-bevacizumab or FOLFIRI-bevacizumab: results from ARIES, a bevacizumab observational cohort study. [electronic resource] by
- Bendell, Johanna C
- Bekaii-Saab, Tanios S
- Cohn, Allen L
- Hurwitz, Herbert I
- Kozloff, Mark
- Tezcan, Haluk
- Roach, Nancy
- Mun, Yong
- Fish, Susan
- Flick, E Dawn
- Dalal, Darshan
- Grothey, Axel
Producer: 20130606
In:
The oncologist vol. 17
Availability: No items available.
|
|
|
5916.
|
|
|
|
5917.
|
|
|
|
5918.
|
ICECREAM: randomised phase II study of cetuximab alone or in combination with irinotecan in patients with metastatic colorectal cancer with either KRAS, NRAS, BRAF and PI3KCA wild type, or G13D mutated tumours. [electronic resource] by
- Segelov, Eva
- Waring, Paul
- Desai, Jayesh
- Wilson, Kate
- Gebski, Val
- Thavaneswaran, Subotheni
- Elez, Elena
- Underhill, Craig
- Pavlakis, Nick
- Chantrill, Lorraine
- Nott, Louise
- Jefford, Michael
- Khasraw, Mustafa
- Day, Fiona
- Wasan, Harpreet
- Ciardiello, Fortunato
- Karapetis, Chris
- Joubert, Warren
- van Hazel, Guy
- Haydon, Andrew
- Price, Tim
- Tejpar, Sabine
- Tebbutt, Niall
- Shapiro, Jeremy
Producer: 20171020
In:
BMC cancer vol. 16
Availability: No items available.
|
|
|
5919.
|
UCN-01 enhances cytotoxicity of irinotecan in colorectal cancer stem-like cells by impairing DNA damage response. [electronic resource] by
- Signore, Michele
- Buccarelli, Mariachiara
- Pilozzi, Emanuela
- De Luca, Gabriele
- Cappellari, Marianna
- Fanciulli, Maurizio
- Goeman, Frauke
- Melucci, Elisa
- Biffoni, Mauro
- Ricci-Vitiani, Lucia
Producer: 20180109
In:
Oncotarget vol. 7
Availability: No items available.
|
|
|
5920.
|
|